St. Jude Medical — Merger or Acquisition (April 2016)
11 slides from St. Jude Medical's merger presentation, Apr 28, 2016
Slide 1: Information Related to This Communication
Information Related to This Communication Important Additional Information In connection with the proposed transaction, Abbott intends to file a registration statement on Form S-4 with the SEC which will include a document that serves as a prospectus of Abbott and a proxy statement of St. Jude Medic
Slide 2: Forward-Looking Statements
Forward-Looking Statements Private Securities Litigation Reform Act of 1995 Caution Concerning Forward-Looking Statements Some statements in this news release may be forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995. Abbott and St. Jude Medical caution t
Slide 3: Transaction Overview
Transaction Overview • • St. Jude Medical shareholders will receive $46.75 in cash and 0.8708 shares of Abbott common stock. At an Abbott stock price of $43.93(1) , this represents a total consideration of $85 per St. Jude Medical share and a total transaction equity value of $25 billion. • The tran
Slide 4: Combination of Abbott and St. Jude Medical Creates A Premier Medical Device Leader
Combination of Abbott and St. Jude Medical Creates A Premier Medical Device Leader Combined business will have one of the broadest portfolios of devices and an industry-leading pipeline to help healthcare systems provide better care for patients while increasing efficiencies and reducing costs. Alig
Slide 5: Background
St. Jude Medical Background Founded in 1976, headquartered in St. Paul, MN with ~18,000 employees worldwide. 2015 Revenue(1) $1.5 billion(2) $1.1 billion $0.5 billion $1.2 billion $1.6 billion • Single and dual chamber pacemakers and implantable cardioverter-defibrillators • Cardiac resynchronizatio
Slide 6: Together, Abbott and St. Jude Medical Hold Leading Positions Across Cardiovascular Device Areas
Together, Abbott and St. Jude Medical Hold Leading Positions Across Large and High-Growth Cardiovascular Device Areas + Cardiovascular Areas of Focus Rank (1) Fractional Flow Reserve and Optical Coherence Tomography 7 Creating A Premier Medical Device Leader | April 27, 2016 Coronary stents #1 PCI O
Slide 7: Abbott Has A Long And Successful Record Of Integrations
Abbott Has A Long And Successful Of Integrations Select examples of Abbott transactions Established Abbott as a top 10 pharmaceutical company in Latin America. 5/16/2014 $2.9 billion • Positioned Abbott as the leading company in the fast-growing Indian pharmaceuticals market. 5/21/2010 $3.7 billion
Slide 8: Combination Creates Industry-Leading Portfolio and New Product Pipeline
Combination Creates Industry-Leading Portfolio and New Product Pipeline = Abbott Products = St. Jude Medical Products 9 Creating A Premier Medical Device Leader | April 27, 2016 ATRIAL FIBRILLATION TactiCath™ FlexAbility™ EnSite Precision™ AmplatzerAmulet™ Confirm™ Topera TRADITIONAL CARDIAC RHYTHM
Slide 9: Highly Strategic and Financially Compelling Combination
Highly Strategic and Financially Compelling Combination • Advances Abbott’s strategic and competitive position Creates a premier medical device leader well-positioned for long-term growth with access to new, high growth therapy areas Diversifies Abbott’s revenue mix and future sources of growth Prov
Slide 10: Summary
Summary Immediately creates a premier medical device leader with top positions in attractive markets and an industry-leading pipeline Highly complementary combination that is well-aligned with Abbott’s strategic priorities Significant value creation through enhanced global scale and capabilities, an
Slide 11: Summary
Summary Immediately creates a premier medical device leader with top positions in attractive markets and an industry-leading pipeline Highly complementary combination that is well-aligned with Abbott's strategic priorities Significant value creation through enhanced global scale and capabilities, an
St. Jude Medical — Merger or Acquisition (April 2016) on 6ix